CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.415

Change

0.00 (0.00)%

Market Cap

USD 0.61B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.56 (+1.27%)

USD 67.33B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.10 (+0.22%)

USD 11.54B
WRD:PA HSBC ETFs Public Limited Compa..

+0.06 (+0.17%)

USD 9.41B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.09 (-0.46%)

USD 7.83B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+3.35 (+0.75%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.13 (+0.24%)

USD 7.02B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.48 (+0.15%)

USD 6.60B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.02 (+0.14%)

USD 5.52B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.73 (+0.20%)

USD 4.87B
500U:PA Amundi Index Solutions - Amund..

+0.36 (+0.34%)

USD 4.29B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.11% 45% F 63% D
Dividend Return N/A 7% C- 92% A
Total Return N/A 50% F 64% D
Trailing 12 Months  
Capital Gain -2.87% 11% F 41% F
Dividend Return N/A 16% F 71% C-
Total Return N/A 1% F 73% C
Trailing 5 Years  
Capital Gain -25.09% 9% A- 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.09% 7% C- 24% F
Average Annual (5 Year Horizon)  
Capital Gain -5.62% 7% C- 21% F
Dividend Return N/A 50% F 59% D-
Total Return N/A 20% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 1% F 82% B
Risk Adjusted Return N/A 51% F 69% C-
Market Capitalization 0.61B 75% C 74% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.